Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: HARD TO BELIEVE

I totally agree. Unreal. Somebody tell me, at this point, how much risk? USPTO?

And how much did PTSC get out of the settlements? IMO, absolutely no less than $50M, EPS of .125/share, ignoring the other recent licensees. So our "real" P/E is under 5?

Anyway, I agree so much that my 5 stars made you a VP! Feel better? Didn't think so....

SGE

Share
New Message
Please login to post a reply